B Lymphocytes Are Critical for Lung Fibrosis Control and Prostaglandin E2 Regulation in IL-9 Transgenic Mice
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
We previously showed that overexpression of IL-9 controls lung fibrosis induced by silica particles in mice (Arras and colleagues; Am J Respir Cell Mol Biol 2001;24:368–375). This protection was associated with an expansion of lung B lymphocytes. To explore the contribution of these cells in the protective effect of IL-9, we crossed IL-9 transgenic (IL-9+) and B-deficient (B−) mice. The antifibrotic effect of IL-9 was abolished in mice deficient in B lymphocytes (B−IL-9+) and restored by reconstituting these mice with B lymphocytes. The expression of the antifibrotic mediator prostaglandin (PG)E2 was markedly increased in the lung of IL-9+ mice at baseline, and similarly high levels were found in both wild-type and transgenic strains upon silica treatment. This PGE2 expression was completely abolished in B− mice, both at baseline and upon silica administration. In vitro, alveolar and peritoneal macrophages from IL-9+ mice had an increased capacity to produce PGE2 in response to LPS or silica. This capacity was markedly reduced in macrophages obtained from B− mice and restored by co-incubating macrophages with B lymphocytes from IL-9+ mice. The increased PGE2 response of IL-9+ macrophages was dependent on cyclooxygenase 2 expression, based on transcript analysis and inhibition by NS398. We conclude that B lymphocytes are essential for the protection against lung fibrosis and macrophage overexpression of PGE2 in IL-9 transgenic animals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“data gleaned in other models show that B cells may actually suppress fibrotic response (171)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [171]
Citations
Cites
Kitamura, D., Roes, J., Kühn, R., & Rajewsky, K. (1991) · Nature · doi:10.1038/350423a0 · Cited by 1,783
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
Macrophages and Polymorphonuclear Neutrophils in Lung Defense and Injury
Sibille, Y., & Reynolds, H. Y. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.2.471 · Cited by 1,083 · cited 1×
“This observation suggests that, in the lung, IL-9 modulates an early process involved in the physiologic differentiation of alveolar macrophages (induced, for example, by oxygen or surfactant components [32], or by airway antigens [33]).”
BackgroundLee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113416 · Cited by 726
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13416 · Cited by 725
Temann, U.-A., Geba, G. P., Rankin, J. A., & Flavell, R. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1307 · Cited by 452
Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling
Holgate, S. T., Peters-Golden, M., Panettieri, R. A., & Henderson, W. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.25 · Cited by 318
Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin.
Thrall, R. S., McCormick, J. R., Jack, R., McReynolds, R. A., & Ward, P. A. (1979) · PubMed Central · Cited by 303
Research works printed but not linked: 6
- 1994, Oncogene, 9, 1327
- 1985, Am Rev Respir Dis, 131, 94
- 1979, Am J Pathol, 95, 117
- 2005, J Dermatol Sci, 39, 1
- 2002, Nat Immunol, 3, 944
- 1989, Am J Pathol, 135, 605
Cited by
Molecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 418
“The presence of B cells was necessary for the protective effect of IL-9, demonstrated by lack of reduction in fibrosis in B cell-deficient mice, and by a restoration of the reduction in fibrosis by B cell reconstitution [178].”
BackgroundThe Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
“However, because data gleaned in other models show that B cells may actually suppress fibrotic response (171), precise understanding of the relationship between B cells and IPF remains elusive and the potential contribution these cells to IPF pathogenesis remains a query in need of further study.”
ResultRole of interleukins in the pathogenesis of pulmonary fibrosis
She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00437-9 · Cited by 219
Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
Ueha, S., Shand, F. H. W., & Matsushima, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00071 · Cited by 182
New developments in the understanding of immunology in silicosis
Huaux, F. (2007) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32802bf8a5 · Cited by 175
Self-citationDysregulation of metabolic pathways in pulmonary fibrosis
Rajesh, R., Atallah, R., & Bärnthaler, T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108436 · Cited by 139
The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung
Wirsdörfer, F., & Jendrossek, V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00591 · Cited by 125
“In contrast, B cells under the influence of IL-9 participated in the protection against lung fibrosis in a murine model of silica particle-induced lung fibrosis, and their protective effect was associated with the overexpression of prostaglandin-E2 (PGE2) in macrophages (183).”
BackgroundIL-13 Mediates In Vivo IL-9 Activities on Lung Epithelial Cells but Not on Hematopoietic Cells
Steenwinckel, V., Louahed, J., Orabona, C., Huaux, F., Warnier, G., McKenzie, A., Lison, D., Levitt, R., & Renauld, J.-C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3244 · Cited by 108
“Interestingly, in a silica-induced lung fibrosis model, the anti-fibrotic effect of IL-9 correlated with increased B cell numbers in BAL (26) and was lost in B cell-deficient mice (47).”
BackgroundSelf-citationTh9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials
Deng, Y., Wang, Z., Chang, C., Lu, L., Lau, C. S., & Lu, Q. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.12.010 · Cited by 117
The cytokines of pulmonary fibrosis: Much learned, much more to learn
Luzina, I. G., Todd, N. W., Sundararajan, S., & Atamas, S. P. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.008 · Cited by 100
Innate immune processes are sufficient for driving silicosis in mice
Beamer, C. A., Migliaccio, C. T., Jessop, F., Trapkus, M., Yuan, D., & Holian, A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0210108 · Cited by 85
Mora, A. L., Torres-González, E., Rojas, M. M., Xu, J., Ritzenthaler, J. D., Speck, S. H., Roman, J., Brigham, K. L., & Stecenko, A. A. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1426oc · Cited by 82
CD19 regulates the development of bleomycin‐induced pulmonary fibrosis in a mouse model
Komura, K., Yanaba, K., Horikawa, M., Ogawa, F., Fujimoto, M., Tedder, T. F., & Sato, S. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23995 · Cited by 80
A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice
Zhu, Y.-J., Liu, Y., Zhou, W., Xiang, R., Jiang, L., Huang, K., Xiao, Y. P., Guo, Z., & Gao, J. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-34 · Cited by 78
Profibrotic Effect of IL-9 Overexpression in a Model of Airway Remodeling
van den Brûle, S., Heymans, J., Havaux, X., Renauld, J., Lison, D., Huaux, F., & Denis, O. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0397oc · Cited by 60
Self-citationIL-9 Blockade Suppresses Silica-induced Lung Inflammation and Fibrosis in Mice
Sugimoto, N., Suzukawa, M., Nagase, H., Koizumi, Y., Ro, S., Kobayashi, K., Yoshihara, H., Kojima, Y., Asae, K.-H., Hebisawa, A., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0287oc · Cited by 63
Yanaba, K., Yoshizaki, A., Asano, Y., Kadono, T., & Sato, S. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110268 · Cited by 53
Regulatory B cells control airway hyperreactivity and lung remodeling in a murine asthma model
Habener, A., Happle, C., Grychtol, R. M., Škuljec, J., Busse, M., Dalüge, K., Obernolte, H., Sewald, K., Braun, A. C., Meyer‐Bahlburg, A., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.09.041 · Cited by 48
Immune Cells in Subretinal Wound Healing and Fibrosis
Szczepan, M., Llorián‐Salvador, M., Chen, M., & Xu, H. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.916719 · Cited by 36
“B cell deficient mice are resistant to silica-induced lung fibrosis (Arras et al., 2006), and carbon tetrachloride-induced liver fibrosis (Thapa et al.”
BackgroundDeleterious Role of Th9 Cells in Pulmonary Fibrosis
Deng, K., Yang, X. S., Luo, Q., She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cells · doi:10.3390/cells10113209 · Cited by 36
Role of p53–fibrinolytic system cross-talk in the regulation of quartz-induced lung injury
Bhandary, Y. P., Shetty, S. K., Marudamuthu, A. S., Fu, J., Pinson, B., Levin, J. L., & Shetty, S. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.01.007 · Cited by 30
“cytokines (Davis et al., 2001; Suzuki et al., 1996; Kumar et al., 1990; Arras et al., 2006) and development of lung fibrosis.”
Manku, G., Papadopoulos, P., Boisvert, A., & Culty, M. (2019) · Andrology · doi:10.1111/andr.12727 · Cited by 21
Gheorghe, K. R., Thurlings, R. M., Westman, M., Boumans, M., Malmström, V., Trollmo, C., Korotkova, M., Jakobsson, P., & Tak, P. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016378 · Cited by 24
“In this sense, it has been reported that B cells are essential in sustaining PGE2 production by lung macrophages [20].”
BackgroundModelos experimentales para el estudio de la fibrosis pulmonar: utilidad práctica actual y futura
Molina‐Molina, M., Pereda, J., & Xaubet, A. (2007) · Archivos de Bronconeumología · doi:10.1157/13109471 · Cited by 18
Experimental Models for the Study of Pulmonary Fibrosis: Current Usefulness and Future Promise
Molina‐Molina, M., Pereda, J., & Xaubet, A. (2007) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(07)60115-3 · Cited by 21
Moog, M., Hinze, C. A., Bormann, T., Aschenbrenner, F., Knudsen, L., DeLuca, D. S., Jonigk, D. D., Neubert, L., Welte, T., Gauldie, J., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100767 · Cited by 17
B lymphocytes in renal interstitial fibrosis
Zhu, F., Bai, X., & Chen, X. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0382-x · Cited by 17
“Since its discovery 50 years ago (Gitlin and Nussenzweig 2015), B cells are largely regarded as active in antibody dependent immune responses.”
BackgroundPeng, X., Liu, T., Huang, H., Yuan, Y. C., Zhang, W., Fu, L., & Chen, Y. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2077755 · Cited by 10
IL-9 Signaling Pathway: An Update
Roy, D. N., & Goswami, R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6877-0_3 · Cited by 10
Hiéronimus, L., Demazy, R., Christiaens, L., Uwambayinema, F., Geuens, J.-F., Yacoub, Y., & Huaux, F. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03200-2 · Cited by 10
Self-citationEnfermedades pulmonares intersticiales difusas
Xaubet, A., Molina‐Molina, M., & Sánchez, M. (2007) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(07)71175-4 · Cited by 12
Boin, F., & Chizzolini, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-31407-5_13 · Cited by 10
B-1 cells in immunotoxicology: Mechanisms underlying their response to chemicals and particles
Hiéronimus, L., & Huaux, F. (2023) · Frontiers in Toxicology · doi:10.3389/ftox.2023.960861 · Cited by 12
“Indeed, in response to silica particles, B cell-deficient mice (μMT-deficient mice) develop few cellular aggregates and deposit less collagen in their lungs, probably due to the loss of pro-fibrotic signals activating macrophages (Arras et al., 2006).”
BackgroundSelf-citationLeinardi, R., Petriglieri, J. R., Pochet, A., Yakoub, Y., Lelong, M., Lescoat, A., Turci, F., Lecureur, V., & Huaux, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015145 · Cited by 12
“Primary peritoneal macrophages were collected from C57BL/6 mice and GSDMD-deficient mice following a procedure established by Arras [74–76].”
MethodSelf-citationLa investigación básica en neumología
Gea, J. (2008) · Archivos de Bronconeumología · doi:10.1157/13128329 · Cited by 7
Gea, J. (2008) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(08)60116-0 · Cited by 7
Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
Tsukui, T., Shichino, S., Shimaoka, T., Ueha, S., & Matsushima, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_2 · Cited by 7
Jiménez‐Gómez, G., Campos‐Caro, A., García-Núñez, A., Gallardo‐García, A., Molina-Hidalgo, A., & León‐Jiménez, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115722 · Cited by 8
Zhu, F., Zuo, L., Hu, R., Wang, J., Yang, Z., Qi, X., & Feng, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.671617 · Cited by 5
“showed that B cells were critical for lung fibrosis control, and it promoted macrophage overexpression of prostaglandin-E2 in IL-9 transgenic mice (20).”
BackgroundReduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
Karampitsakos, Τ., Παπαϊωάννου, Ο., Dimeas, I. E., Tsiri, P., Sotiropoulou, V., Tomos, I. P., Papanikolaou, I. C., Katsaras, M., Kirgou, P., Daniil, Z. D., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00082-2022 · Cited by 3
Jehn, L. B., Costabel, U., Boerner, E. B., Wessendorf, T., Theegarten, D., Taube, C., & Bonella, F. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152258 · Cited by 5
Boin, F., & Chizzolini, C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-5774-0_15 · Cited by 2
Sex Differences in Adaptive Immunity in Chronic Lung Disease
Chowdhury, N. U., Gandhi, V. D., & Newcomb, D. C. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-63549-7_11 · Cited by 1
A protective role for B-1 cells and oxidation-specific epitope IgM in lung fibrosisPreprint
Sturek, J. M., Hannan, R. T., Upadhye, A., Otoupalova, E., Faron, E. T., Atya, A. A. E., Thomas, C., Johnson, V., Miller, A., Garmey, J. C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.11.589137 · Cited by 1
Is Immune Response Relevant in Interstitial Lung Disease?
Khan, M. M. (2020) · Current Immunology Reviews · doi:10.2174/1573395516999200914143054
(CAVEOLIN-1: A CRITICAL REGULATOR OF INFLAMMATION AND FIBROSIS)
Wang, X. M. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Metadata
- Authors
- Arras, M., Louahed, J., Simoen, V., Barbarin, V., Misson, P., van den Brûle, S., Delos, M., Knoops, L., Renauld, J.-C., Lison, D., & Huaux, F.
- Affiliations
- Ludwig Cancer Research (BE)
- Unit of Industrial Toxicology and Occupational Medicine, Unit of Experimental Medicine and Ludwig Institute for Cancer Research, Faculty of Medicine, and Laboratory of Pathology, University Hospital of Mont-Godinne, Yvoir, Université catholique de Louvain, Brussels, Belgium
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-01
- Volume
- 34
- Issue
- 5
- Pages
- 573-580
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2165549059
- Cited by
- 46
- References
- 50
- Citations by year
- 2024: 2 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 1 · 2014: 1 · 2012: 2
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- IL-9, pulmonary fibrosis, B cells, prostaglandin E2, macrophages, cyclooxygenase-2, silica-induced fibrosis, B cell deficiency
- MeSH terms
- Prostaglandin-E Synthases, Animals, B-Lymphocytes, Bronchoalveolar Lavage Fluid, Collagen, Female, Gene Expression Regulation, Lung, Mice, Transgenic, Pulmonary Fibrosis, Silicon Dioxide, Subcellular Fractions, Dinoprostone, Macrophages, Alveolar, Interleukin-9, Macrophages, Peritoneal, Intramolecular Oxidoreductases, Mice, Cyclooxygenase 1, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.